Effects in Israel of Arab and Jewish Ethnicity on Intracerebral Hemorrhage.
Arab ethnicity
Jewish ethnicity
hypertensive arteriopathy
intracerebral hemorrhage
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
11 Apr 2022
11 Apr 2022
Historique:
received:
20
10
2021
revised:
27
02
2022
accepted:
08
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
24
4
2022
Statut:
epublish
Résumé
Intracerebral hemorrhages (ICH) characteristics reportedly differ between different ethnic groups. We aimed to compare the characteristics of Jewish and Arab ICH patients in Israel. Consecutive patients with primary ICH were included in a prospective institutional database. Demographics, vascular risk factors, clinical and radiological parameters were compared between Arab and Jewish ICH patients residing in Jerusalem. The study included 455 patients (311 Jews). Arab patients were younger (66.1 ± 13.4 vs. 72.2 ± 12.2 years, p < 0.001) and had higher rates of diabetes (60% vs. 29%, p < 0.001) and smoking (26% vs. 11%, p < 0.001). Arab patients had higher rates of deep ICH (74% vs. 62%, p = 0.01) and lower rates of lobar ICH (18% vs. 31%, p = 0.003). In a sub-analysis of deep ICH patients only, Arab patients were younger (64.3 ± 12.9 vs. 71.4 ± 11.8 years, p < 0.001) and less frequently male (56% vs. 68%, p = 0.042), with higher rates of diabetes (61% vs. 35%, p < 0.001) and smoking (31% vs. 14%, p < 0.001). In conclusion, the two ethnic populations in Israel differ in the causes and attributes of ICH. Heavy smoking and poorly controlled diabetes are commonly associated with deep ICH in the Arab population and may offer specific targets for secondary prevention in this population.
Identifiants
pubmed: 35456208
pii: jcm11082117
doi: 10.3390/jcm11082117
pmc: PMC9024802
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Am J Epidemiol. 2004 Aug 15;160(4):376-83
pubmed: 15286023
Diabetes Care. 2019 Apr;42(4):682-688
pubmed: 30728223
Lancet Neurol. 2009 Apr;8(4):355-69
pubmed: 19233729
Stroke. 2016 Apr;47(4):929-35
pubmed: 26869385
Curr Opin Neurol. 2001 Feb;14(1):103-8
pubmed: 11176225
Neurol Clin. 2000 May;18(2):419-38
pubmed: 10757834
Lancet Glob Health. 2013 Nov;1(5):e259-81
pubmed: 25104492
Neurology. 1996 Aug;47(2):405-8
pubmed: 8757012
Stroke. 2013 Jun;44(6):1578-83
pubmed: 23559261
Circulation. 2016 Nov 8;134(19):1444-1452
pubmed: 27737957
J Stroke. 2021 Jan;23(1):37-50
pubmed: 33600701
Front Neurol Neurosci. 2015;37:1-12
pubmed: 26588164
J Stroke Cerebrovasc Dis. 2016 Apr;25(4):872-6
pubmed: 26803722
Lancet Neurol. 2010 Feb;9(2):167-76
pubmed: 20056489
Neurology. 2005 Aug 23;65(4):518-22
pubmed: 16116109
J Neurol Sci. 2021 Apr 15;423:117357
pubmed: 33725592
J Stroke Cerebrovasc Dis. 2010 Sep-Oct;19(5):376-81
pubmed: 20472467
Cerebrovasc Dis. 2011;31(5):506-10
pubmed: 21411992
Am J Hum Genet. 2014 Apr 3;94(4):511-21
pubmed: 24656865
Stroke. 2005 May;36(5):934-7
pubmed: 15790947
Lancet. 2010 Jul 10;376(9735):112-23
pubmed: 20561675
Neurology. 2021 May 18;96(20):e2469-e2480
pubmed: 33883240
Am J Epidemiol. 2001 Dec 1;154(11):1057-63
pubmed: 11724723
Int J Environ Res Public Health. 2020 Dec 09;17(24):
pubmed: 33316905
Stroke. 2009 Feb;40(2):394-9
pubmed: 19038914
Acta Neurol Scand. 1993 May;87(5):367-70
pubmed: 8333240
Int J Stroke. 2014 Oct;9(7):840-55
pubmed: 25156220
Stroke. 2006 Jan;37(1):63-8
pubmed: 16306469
Mo Med. 2011 Jan-Feb;108(1):50-4
pubmed: 21462612